Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Proniras
2815 Eeastlake Ave. E, Ste. 300
Seattle, WA 98102
Phone: 206-957-7300
http://proniras.com/

Proniras Corporation is a Seattle-based biopharmaceutical company focused on developing tezampanel as a medical countermeasure for nerve agent-induced seizures. The development of tezampanel in this indication is being funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201800008C.

Key Contact
Name
Christopher Toombs
Title
Co-Founder
Funding Events

Date
Amount
Type
Investors
Valuation
04/27/18 undisclosed Accelerator Life Science Partners
Alexandria Real Estate Equities
ARCH Venture Partners
Eli Lilly and Company
Johnson & Johnson Innovation
Watson Fund
WRF Capital
WuXi AppTec
undisclosed
02/01/24 $4,650,000 Series B Accelerator Life Science Partners
ARCH Venture Partners
Watson Fund
WRF Capital
undisclosed